Literature DB >> 15358119

Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus.

Hiroshi Watanabe1, Tomomi Seino, Yukio Sato.   

Abstract

Sera from patients with neuropsychiatric lupus (NP lupus) were screened for antibodies to mouse choroid plexus cell line ECPC-4 by Western blotting. A 29-kDa protein band detected in NP lupus sera was identified as triosephosphate isomerase (TPI). Using Western blotting with TPI, TPI was confirmed as the reactive molecule in sera (6 of 14 samples) and in cerebrospinal fluids (1 of 2 samples) of patients with NP lupus. Enzyme-linked immunosorbent assay with TPI showed that the serum anti-TPI antibody index of 89.8 (SD, 70.1) in NP lupus group was significantly higher than in systemic lupus erythematosus without NP manifestations, 34.6 (29.6); scleroderma, 38.2 (39.9); polymyositis/dermatomyositis, 42.1 (51.5); and control, 31.7 (27.4) groups (p<0.02). Sensitivity, specificity, and positive and negative likelihood ratios of serum anti-TPI antibody index for NP lupus were 42.9%, 94.7%, 8.1%, and 0.6%, respectively. These results suggest that anti-TPI antibodies are closely associated with NP lupus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358119     DOI: 10.1016/j.bbrc.2004.07.051

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis.

Authors:  Xiao-ye Lu; Xiao-xiang Chen; Li-dong Huang; Chang-qing Zhu; Yue-ying Gu; Shuang Ye
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

2.  Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Shuzo Sato; Makiko Yashiro; Tomoyuki Asano; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Clin Rheumatol       Date:  2017-04-28       Impact factor: 2.980

3.  Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity.

Authors:  C M McClelland; W J Gullick
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

Review 4.  Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.

Authors:  Ariel D Stock; Jing Wen; Chaim Putterman
Journal:  Front Immunol       Date:  2013-12-25       Impact factor: 7.561

Review 5.  Salivary Biomarkers in Systemic Sclerosis Disease.

Authors:  Zeineb Zian; Joaira Bakkach; Amina Barakat; Naima Ghailani Nourouti; Mohcine Bennani Mechita
Journal:  Biomed Res Int       Date:  2018-03-12       Impact factor: 3.411

Review 6.  Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers.

Authors:  Shuzo Sato; Jumpei Temmoku; Yuya Fujita; Makiko Yashiro-Furuya; Naoki Matsuoka; Tomoyuki Asano; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2020-03-13

Review 7.  Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?

Authors:  Elias Manca
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-11       Impact factor: 10.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.